HUL Divests Entire Wellbeing Nutrition Stake for ₹307 Crore, Gains Full OZiva Ownership

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

HUL Sells Wellbeing Nutrition Stake for ₹307 Cr, Acquires Full Control of OZiva

HUL Sells Wellbeing Nutrition Stake for ₹307 Cr, Acquires Full Control of OZiva

C

CNBC TV18•04-03-2026, 21:10

HUL Sells Wellbeing Nutrition Stake for ₹307 Cr, Acquires Full Control of OZiva

•Hindustan Unilever Ltd (HUL) sold its entire 19.8% stake in Nutritionalab (Wellbeing Nutrition) for approximately ₹307 crore.
•The company will acquire the remaining 49% stake in Zywie Ventures Private Limited for ₹824 crore, making OZiva a wholly-owned subsidiary.
•HUL entered the health and wellbeing segment in 2022 with strategic investments in OZiva and Wellbeing Nutrition.
•Both the divestment of Wellbeing Nutrition and the acquisition of full control of OZiva are expected to close by next month.
•HUL also announced a ₹2,000 crore investment for manufacturing expansion and completed the demerger of its ice cream business.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Shareholders who had shares of Adani Enterprises as of Friday's closing, will be eligible to participate in the rights issue, which will open for subscription on Tuesday, November 25, and close on Wednesday, December 10, 2025. Those who buy shares of the company today, will not be eligible to participate in the rights issue.

Adani arm completes full acquisition of DP Jain TOT Toll Roads

Bulk Deals on March 19

Craft Emerging Market Fund Acquires 2.57% Stake in Rajputana Stainless on Listing Day

Top Stocks in Focus: BSE, HUL, Polycab, Gujarat Gas, Bharat Forge & More on March 5

Top Stocks in Focus: BSE, HUL, Polycab, Gujarat Gas, Bharat Forge & More on March 5

Ashok Leyland share price, Ashok Leyland stock, Ashok Leyland shares, Ashok Leyland, Ashok Leyland brokerage, Ashok Leyland rating, Ashok Leyland target price, Ashok Leyland price target, Ashok Leyland buy or sell, buy or sell Ashok Leyland, Ashok Leyland buy, buy Ashok Leyland, BoFa Securities, Ashok Leyland brokerage,

Ashok Leyland Boosts UK Unit Optare Stake to 93.28% with ₹375 Crore Investment

OneSource Specialty Pharma को National Stock Exchange of India Limited और BSE Limited से ड्राफ्ट कंपोजिट स्कीम ऑफ अरेंजमेंट और अमलगमेशन (विलय) के संबंध में No Objection / No Adverse Observation Letter प्राप्त हुआ है. यह प्रस्तावित योजना Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited और Onesource Specialty Pharma Limited के बीच विलय से संबंधित है.

Tech Mahindra Subsidiary Acquires Midad's 20% Stake in TMAL for ₹206 Crore

Bikaji Foods Acquires Petunt Food for Rs 8 Crore, Gains Full Control